Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer

Journal Name: Drug Metabolism and Personalized Therapy Volume: 34 Issue: 2 Pages: null-null
Source: Drug Metabolism and Personalized Therapy - Category: Drugs & Pharmacology Source Type: research